Deep Bio Joins CancerX to Revolutionize Cancer Diagnosis and Prognosis with...
Deep Bio, a leading AI healthcare company specializing in deep learning and cancer pathology, is proud to announce its participation in the groundbreaking CancerX...
Dr Anil K. D’Cruz is now associated with Apollo Hospitals as...
Apollo Hospitals recently announced that renowned senior Oncologist, Dr Anil K. D’Cruz has joined the group as Director, Oncology – Apollo Hospitals, Mumbai, Chennai and Delhi.
The United States releases BlackArmor Anterior Cervical Plate
icotec ag, leading medical device manufacturer of BlackArmor Carbon/PEEK implants, the United States releases the world's first 100% nonmetallic (Plate & Screws) Anterior Cervical...
CE Mark approval for SENSEI-Robotic Gamma Probe
Lightpoint Medical received CE Mark approval for SENSEI, a robotic gamma probe. It is to be commercially available to European hospital systems. SENSEI has...
Probeam 360°
The new ProBeam 360° Proton Therapy System is designed for next-generation proton therapy.
INTEGRA Biosciences’ pipettes help to advance cancer drug discovery
The Institute for Cancer Research (ICR), part of the University of London, is using VIAFLO electronic pipettes from INTEGRA Biosciences to streamline its preclinical drug screening and translational medicine...
Successful haploidentical stem cell transplantation grants new life to a 4-year-Old...
The American Oncology Institute (AOI) in Hyderabad accomplished a medical milestone by successfully treating Deepika, a 4-year-old girl, with innovative haploidentical stem cell transplantation...
Olympus launched HANAROSTENT Esophagus TTS Stent
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, launched HANAROSTENT Esophagus TTS self-expanding metal stents (SEMS)...
McKesson launches Ontada
McKesson launches Ontada, an oncology technology and insights business dedicated to help advance cancer research and care.
FemTech supports the government’s cervical cancer screening project
MobileODT, an Israeli Digital Health FemTech company's latest innovation in cervical cancer screening, Visual Check AI technology, is supporting a large-scale, government cervical cancer...
Cervical Cancer Patient Saved By Early Diagnosis And Treatment At AOI...
A Calicut based 58-year-old female diagnosed with carcinoma of cervix, commonly known as cervical cancer that forms in tissues of the cervix (the organ...
Fluidx Medical Technology releases its clinical study on the use of...
Fluidx Medical Technology, Inc. released details on the clinical use of their GPX Embolic Device for blocking flow to small microvasculature and large tumor...
Lightpoint Medical receives CE Mark approval for Robotic Gamma Probe
Lightpoint Medical, a medical device company developing miniaturized surgical tools for advanced intraoperative cancer detection, received CE Mark approval for SENSEI, a robotic gamma...
The Eclipse Platform to accelerate Research and Development of medicines
Synthego, the genome engineering company, launched Eclipse. Eclipse is a new high-throughput cell engineering platform designed to accelerate drug discovery and validation by providing...
Synchrony of Advanced Technology used with Lithotripsy: Complex Heart Treatment on...
An Indian doctor, using technology- traditionally used to crush kidney stones and with heart pump support, performed a complex heart treatment on 81 year old cancer survivor. A review of medical journals and literature in the field reveals that this is probably the first successful instance of this kind of treatment; successfully used even at the global level, to clear hard and rocky blocks in the heart and limb.
SkylineDx signs a collaboration agreement with multiple stakeholders
SkylineDx signed a collaboration agreement with a multi-disciplinary clinical consortium in the Netherlands that designed a trial to implement a diagnostic innovation to manage continuity of care delivery, due to COVID.
In an attempt to put an end to cancer
On the world cancer day which is observed on 4th February every year with this year theme ‘I Am and I Will’ the experts from medical industry share their insights and awareness about the cancer. 2020 marks the halfway point of the 3-year ‘I Am and I Will’ campaign - by Neha Wagle, Sub-Editor.
Virtual Biopsy
The new “virtual biopsy” device relies on vibrational optical coherence tomography to analyse tissue.
SmartBreast acquires Molecular Breast Imaging
SmartBreast Corporation (SmartBreast), a privately held company focused on breast cancer screening and diagnosis, acquired the Discovery NM750b Molecular Breast Imaging (MBI) assets from...
Healing cooling systems in medicine: Technotrans widens focus on the healthcare...
In the market of healthcare & analytics, Technotrans SE is broadening its solution competence. The thermal management specialist is currently working on several new cooling...